CN103203014A - 一种共混功能性手术冲洗液的制备方法 - Google Patents
一种共混功能性手术冲洗液的制备方法 Download PDFInfo
- Publication number
- CN103203014A CN103203014A CN2013100703695A CN201310070369A CN103203014A CN 103203014 A CN103203014 A CN 103203014A CN 2013100703695 A CN2013100703695 A CN 2013100703695A CN 201310070369 A CN201310070369 A CN 201310070369A CN 103203014 A CN103203014 A CN 103203014A
- Authority
- CN
- China
- Prior art keywords
- stirring
- solution
- preparation
- carboxymethyl cellulose
- functional surgical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000661 sodium alginate Substances 0.000 claims abstract description 10
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 10
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 10
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 10
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 10
- 102000016943 Muramidase Human genes 0.000 claims abstract description 9
- 108010014251 Muramidase Proteins 0.000 claims abstract description 9
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 9
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 9
- 239000004325 lysozyme Substances 0.000 claims abstract description 9
- 229960000274 lysozyme Drugs 0.000 claims abstract description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000008213 purified water Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 5
- 239000011780 sodium chloride Substances 0.000 claims abstract description 4
- 230000008961 swelling Effects 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims description 20
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000000630 rising effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 6
- 230000035876 healing Effects 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 15
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000002464 physical blending Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310070369.5A CN103203014B (zh) | 2013-03-06 | 2013-03-06 | 一种共混功能性手术冲洗液的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310070369.5A CN103203014B (zh) | 2013-03-06 | 2013-03-06 | 一种共混功能性手术冲洗液的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103203014A true CN103203014A (zh) | 2013-07-17 |
CN103203014B CN103203014B (zh) | 2015-02-25 |
Family
ID=48750566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310070369.5A Active CN103203014B (zh) | 2013-03-06 | 2013-03-06 | 一种共混功能性手术冲洗液的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103203014B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103977449A (zh) * | 2014-06-04 | 2014-08-13 | 张巍 | 一种共混液体止血复合材料及其制备方法 |
CN104606224A (zh) * | 2015-01-13 | 2015-05-13 | 河北柯瑞生物医药有限公司 | 一种清洗液及其制备方法 |
CN105796596A (zh) * | 2016-03-11 | 2016-07-27 | 张�杰 | 一种外科手术平衡盐冲洗液及其制备方法 |
CN106361764A (zh) * | 2016-08-29 | 2017-02-01 | 沂水县人民医院 | 一种肝癌手术切口用冲洗液 |
CN110151686A (zh) * | 2018-04-13 | 2019-08-23 | 山东虎力机械有限公司 | 一种眼科手术后用冲洗液及其制备方法 |
CN111760018A (zh) * | 2020-06-11 | 2020-10-13 | 江苏开源康达医疗器械有限公司 | 一种高效抑菌消炎的生物多糖冲洗液及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616092A (zh) * | 2004-10-19 | 2005-05-18 | 上海新药研究开发中心 | 复合溶菌酶Lysoamidase喷雾剂及制备方法 |
CN1672688A (zh) * | 2004-03-24 | 2005-09-28 | 阴法义 | 医用复合甲壳胺凝胶液 |
CN101559047A (zh) * | 2008-04-16 | 2009-10-21 | 郭进军 | 木糖醇赤藓糖醇在伤口冲洗中的作用 |
CN101693039A (zh) * | 2009-10-14 | 2010-04-14 | 北京普瑞博思投资有限公司 | 一种用于手术冲洗的药物组合物 |
US20110251137A1 (en) * | 2010-04-09 | 2011-10-13 | National Health Research Institutes | Gamma-polyglutamic acid-based ocular irrigating solutions |
CN102850598A (zh) * | 2012-08-31 | 2013-01-02 | 稳健实业(深圳)有限公司 | 海藻酸盐-明胶-羧甲基纤维素钠共混膜及其制备和应用 |
-
2013
- 2013-03-06 CN CN201310070369.5A patent/CN103203014B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1672688A (zh) * | 2004-03-24 | 2005-09-28 | 阴法义 | 医用复合甲壳胺凝胶液 |
CN1616092A (zh) * | 2004-10-19 | 2005-05-18 | 上海新药研究开发中心 | 复合溶菌酶Lysoamidase喷雾剂及制备方法 |
CN101559047A (zh) * | 2008-04-16 | 2009-10-21 | 郭进军 | 木糖醇赤藓糖醇在伤口冲洗中的作用 |
CN101693039A (zh) * | 2009-10-14 | 2010-04-14 | 北京普瑞博思投资有限公司 | 一种用于手术冲洗的药物组合物 |
US20110251137A1 (en) * | 2010-04-09 | 2011-10-13 | National Health Research Institutes | Gamma-polyglutamic acid-based ocular irrigating solutions |
CN102850598A (zh) * | 2012-08-31 | 2013-01-02 | 稳健实业(深圳)有限公司 | 海藻酸盐-明胶-羧甲基纤维素钠共混膜及其制备和应用 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103977449A (zh) * | 2014-06-04 | 2014-08-13 | 张巍 | 一种共混液体止血复合材料及其制备方法 |
CN103977449B (zh) * | 2014-06-04 | 2015-12-30 | 张巍 | 一种共混液体止血复合材料及其制备方法 |
CN104606224A (zh) * | 2015-01-13 | 2015-05-13 | 河北柯瑞生物医药有限公司 | 一种清洗液及其制备方法 |
CN105796596A (zh) * | 2016-03-11 | 2016-07-27 | 张�杰 | 一种外科手术平衡盐冲洗液及其制备方法 |
CN106361764A (zh) * | 2016-08-29 | 2017-02-01 | 沂水县人民医院 | 一种肝癌手术切口用冲洗液 |
CN110151686A (zh) * | 2018-04-13 | 2019-08-23 | 山东虎力机械有限公司 | 一种眼科手术后用冲洗液及其制备方法 |
CN110151686B (zh) * | 2018-04-13 | 2021-08-03 | 葛强 | 一种眼科手术后用冲洗液及其制备方法 |
CN111760018A (zh) * | 2020-06-11 | 2020-10-13 | 江苏开源康达医疗器械有限公司 | 一种高效抑菌消炎的生物多糖冲洗液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103203014B (zh) | 2015-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103203014B (zh) | 一种共混功能性手术冲洗液的制备方法 | |
CN102836465B (zh) | 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用 | |
CN101053670B (zh) | 一种丝素和聚乳酸复合膜及其制备方法 | |
CN102433006B (zh) | 一种温敏性溶胶-凝胶转化材料的制备方法 | |
CN105536039A (zh) | 一种可吸收流体止血材料及其制备方法与应用 | |
CN102078638A (zh) | 一种长效组合型伤口敷料及其制备方法 | |
CN103751833B (zh) | 一种医用抗菌创伤敷料及其制备方法 | |
CN101664562A (zh) | 创伤修复水凝胶材料及制备方法 | |
CN100387238C (zh) | 医用止血防粘连冲洗液 | |
CN103736135A (zh) | 一种医用复合敷料及其制备方法 | |
CN104906626A (zh) | 可吸收降解的生物相容性止血材料及其制备方法 | |
CN107029282A (zh) | 一种温敏性医用壳聚糖衍生物制剂及其制备方法 | |
CN103083712A (zh) | 掺入有干细胞或其它生物活性物质的外科敷料 | |
CN108498855B (zh) | 一种抗菌止血溶胶及其制备方法 | |
CN106390179B (zh) | 一种具有防粘连止血功能的聚氨酯海绵敷料及其制备方法 | |
CN104307031B (zh) | 一种皮肤外用修复材料的制备方法及用途 | |
CN103550248B (zh) | 一种细菌纤维素/壳聚糖复合喷膜剂及其制备方法 | |
CN107029281A (zh) | 一种可吸收止血材料的制备方法 | |
CN110876814A (zh) | 一种富含抗菌肽的液体创可贴及其制备方法 | |
CN104984383A (zh) | 一种治疗烧伤创面的新型水凝胶敷料及其制备方法 | |
CN104353130A (zh) | 一种手术防粘连膜及其制备方法 | |
CN115887732B (zh) | 一种医用明胶敷料及其制备方法 | |
CN102091057B (zh) | 一种制备载药生物膜的方法 | |
CN105126158B (zh) | 多糖纤维素止血隔离抗菌修复胶液及其制备方法 | |
CN103341204A (zh) | 一种抗菌修复材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HARBIN CHURUN MEDICAL EQUIPMENT CO., LTD. Free format text: FORMER OWNER: ZHANG WEI Effective date: 20141202 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cheng Yu Inventor after: Zhang Wei Inventor after: Zhao Ahua Inventor before: Zhang Wei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150040 HARBIN, HEILONGJIANG PROVINCE TO: 150069 HARBIN, HEILONGJIANG PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHANG WEI TO: CHENG YU ZHANG WEI ZHAO AHUA |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141202 Address after: 150069 Heilongjiang Province, Harbin Economic Development Zone haping Road District No. 27 Bohai road three Applicant after: HRB CHURUN MEDICAL EQUIPMENT CO., LTD. Address before: 301, room 4, unit 24, Hua Hua Street, Power District, Heilongjiang, Harbin 150040, China Applicant before: Zhang Wei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |